Wesseling Sebastiaan, Joles Jaap A, van Goor Harry, Bluyssen Hans A, Kemmeren Patrick, Holstege Frank C, Koomans Hein A, Braam Branko
Nephrology and Hypertension, Netherlands.
Physiol Genomics. 2007 Jan 17;28(2):158-67. doi: 10.1152/physiolgenomics.00077.2006. Epub 2006 Oct 17.
Nitric oxide (NO) depletion in rats induces severe endothelial dysfunction within 4 days. Subsequently, hypertension and renal injury develop, which are ameliorated by alpha-tocopherol (VitE) cotreatment. The hypothesis of the present study was that NO synthase (NOS) inhibition induces a renal cortical antioxidative transcriptional response and invokes pro-oxidative and proinflammatory gene expression due to elimination of dampening effects of NO and enhanced oxidative stress. Male Sprague-Dawley rats received NOS inhibitor N(omega)-nitro-l-arginine (l-NNA, 500 mg/l water) for 4 (4d-LNNA), 21 (21d-LNNA), or 21 days with VitE in chow (0.7 g/kg body wt/day). Renal cortical RNA was applied to oligonucleotide rat arrays. In 4d-LNNA, 21d-LNNA, and 21d-LNNA+VitE, 120, 320, and 184 genes were differentially expressed, respectively. Genes related to glutathione and bilirubin synthesis were suppressed during 4d and 21d-LNNA and not corrected by VitE. Proteinuria, tubulointerstitial macrophages, and heme-oxygenase-1 (HO-1) expression were strongly correlated. Remarkably, pro-oxidative genes were not induced. Inflammation- and injury-related genes, including kidney injury molecule-1 and osteopontin, were unchanged at day 4, induced at 21d, and partly corrected by VitE. Superimposing HO-1 inhibition on NOS inhibition had no impact on the development of hypertension. To summarize, renal expression of genes involved in synthesis of the antioxidants glutathione and bilirubin seemed directly NO dependent, but there were no direct effects of NO depletion on pro-oxidant systems. This indicates that renal transcriptional regulation of two defense systems, glutathione and bilirubin syntheses, seems to depend upon adequate NO synthesis. Interaction between NO synthesis and heme degradation pathways for blood pressure regulation was not found.
大鼠体内一氧化氮(NO)耗竭会在4天内引发严重的内皮功能障碍。随后会出现高血压和肾损伤,而α-生育酚(维生素E)联合治疗可改善这些情况。本研究的假设是,一氧化氮合酶(NOS)抑制会引发肾皮质抗氧化转录反应,并由于消除了NO的抑制作用和增强氧化应激而引发促氧化和促炎基因表达。雄性Sprague-Dawley大鼠饮用含NOS抑制剂N(ω)-硝基-L-精氨酸(L-NNA,500 mg/L水)的水4周(4d-LNNA)、21周(21d-LNNA),或在饲料中添加维生素E(0.7 g/kg体重/天)饮用21周(21d-LNNA+VitE)。将肾皮质RNA应用于寡核苷酸大鼠芯片。在4d-LNNA组、21d-LNNA组和21d-LNNA+VitE组中,分别有120、320和184个基因差异表达。在4d-LNNA组和21d-LNNA组中,与谷胱甘肽和胆红素合成相关的基因受到抑制,且维生素E无法纠正这种抑制。蛋白尿、肾小管间质巨噬细胞和血红素加氧酶-1(HO-1)表达密切相关。值得注意的是,促氧化基因未被诱导。与炎症和损伤相关的基因,包括肾损伤分子-1和骨桥蛋白,在第4天未发生变化,在第21天被诱导,且部分被维生素E纠正。在NOS抑制的基础上叠加HO-1抑制对高血压的发展没有影响。总之,参与抗氧化剂谷胱甘肽和胆红素合成的基因在肾中的表达似乎直接依赖于NO,但NO耗竭对促氧化系统没有直接影响。这表明肾中谷胱甘肽和胆红素合成这两种防御系统的转录调控似乎依赖于充足的NO合成。未发现NO合成与血红素降解途径之间在血压调节方面的相互作用。